Related Experiment Video
Updated: Apr 8, 2026

06:45
Loneliness Assuaged: Eye-Tracking an Audience Watching Barrage Videos
Published on: May 29, 2020
4.7K
Loneliness as an Interface Between Alzheimer's Disease and Suicidal Behaviour: A Systematic Review, Meta-Analysis and
Juliano Flávio Rubatino Rodrigues1,2,3, Lívia Peregrino Rodrigues4, Taiki Teshima5,6
1Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto, São Paulo, Brazil.
Summary
Loneliness is linked to Alzheimer's disease (AD) and suicidal behaviors. Addressing loneliness, hopelessness, and insomnia is crucial for preventing both AD and suicide.
Area of Science:
- Mental Health
- Neuroscience
- Public Health
Background:
- Loneliness is a growing public health concern, impacting mental well-being across demographics.
- It is associated with increased risks of anxiety, depression, and despair.
- The disconnect in a hyper-connected world exacerbates feelings of isolation.
Purpose of the Study:
- To investigate the relationship between loneliness, Alzheimer's disease (AD), and suicidal behavior.
- To explore loneliness as a potential interface between AD and suicidal behavior.
- To identify key factors associated with loneliness in this context.
Main Methods:
- Systematic review following PRISMA guidelines, conducted dichotomously.
- Two separate systematic reviews: one on loneliness and AD, the other on loneliness and suicidal behavior.
- Meta-analysis and meta-analytic factor analysis to examine the interface between AD and suicidal behavior via loneliness.
Main Results:
- Loneliness is significantly associated with Alzheimer's disease (OR=1.89).
- Loneliness shows strong associations with suicidal ideation (OR=2.17), planning (OR=2.36), attempts (OR=2.54), and completed suicide (OR=4.9).
- Entrapment, hopelessness, insomnia, and stress significantly correlate with loneliness, particularly at the interface of AD and suicidal behavior.
Conclusions:
- Loneliness is a comorbid factor linking Alzheimer's disease and suicide.
- Monitoring stress, insomnia, entrapment, and hopelessness is vital for preventing AD and suicide.
- The triad of loneliness, hopelessness, and insomnia represents a significant risk profile.
Related Concept Videos
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Depressive Disorders: Etiology
866
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
866
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Long-term Depression
33.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.8K
Long-term Depression
3.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.6K
Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K

